(Press-News.org)
Embargoed for release: Wednesday, March 20, 5:00 PM ET
Key points:
In a study of 4.3 million pregnant women and their children, prenatal exposure to topiramate, an antiseizure medication used to treat epilepsy, bipolar disorder, and migraines, was not associated with additional risk of the children developing autism spectrum disorder (ASD).
Consistent with previous research, the study also found that prenatal exposure to valproate and lamotrigine—two other antiseizure medications—were associated with a higher risk and no additional risk, respectively, for children developing ASD.
Boston, MA—Topiramate—an antiseizure medication prescribed to treat epilepsy as well as migraines and bipolar disorder—does not appear to increase the risk of autism spectrum disorder (ASD) among children exposed to it prenatally, according to a new study led by Harvard T.H. Chan School of Public Health.
The study will be published on March 21, 2024, in the New England Journal of Medicine.
Many studies have examined the neurodevelopmental impacts of prenatal exposure to valproate and lamotrigine, two other antiseizure medications commonly taken by people living with epilepsy. Most of these studies have linked valproate to a heightened risk of ASD among children exposed to it prenatally but have found no additional risk linked to lamotrigine. Research into the neurodevelopmental safety of topiramate, meanwhile, has been limited, with mixed findings.
“Our findings provide needed clarity on the possible neurodevelopmental impacts of this commonly used drug,” said lead author Sonia Hernández-Díaz, professor of epidemiology. “While our primary analyses focused on mothers with epilepsy, the study has implications for moms and moms-to-be who live with other conditions treated by topiramate as well.”
Using data recorded between 2000 and 2020 across two U.S. health care databases, the researchers identified a population-based cohort of nearly 4.3 million pregnant women and their children. Children who had been exposed to topiramate during the second half of pregnancy were compared with children who had never been exposed to an antiseizure medication prenatally, with respect to the risk of ASD. Children who had been exposed to valproate and lamotrigine during the second half of pregnancy were used as control groups.
The study found that at age 8, children born to mothers with epilepsy had a higher prevalence of ASD compared to children in the general population. Within the full study population, 1.9% of children who had never been prenatally exposed to an antiseizure medication were diagnosed with ASD. For children born to mothers with epilepsy, the incidence was 4.2% with no exposure to an antiseizure medication; 6.2% with exposure to topiramate; 10.5% with valproate; and 4.1% with lamotrigine. However, after adjusting for confounding variables, the researchers concluded that prenatal exposure to topiramate and lamotrigine was no longer associated with additional risk of developing ASD, while prenatal exposure to valproate remained associated with additional risk.
The researchers noted that this relationship between valproate and ASD is dose-dependent, and that while topiramate appears safe from a neurodevelopmental standpoint, it remains linked with a higher risk of oral clefts. They also noted certain limitations of the study, including a substantial portion of children in the study population being lost to follow up before age 8.
Krista Huybrechts, associate professor in the Department of Epidemiology, was also a co-author.
The study was funded by the National Institute of Mental Health (grant R01MH116194).
“Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure,” Sonia Hernández-Díaz, Loreen Straub, Brian T. Bateman, Yanmin Zhu, Helen Mogun, Katherine L. Wisner, Kathryn J. Gray, Barry Lester, Christopher J. McDougle, Elyse DiCesare, Page B. Pennell, Krista F. Huybrechts, The New England Journal of Medicine, March 21, 2024, doi: 10.1056/NEJMoa2309359
Visit the Harvard Chan School website for the latest news, press releases, and multimedia offerings.
###
Harvard T.H. Chan School of Public Health brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. As a community of leading scientists, educators, and students, we work together to take innovative ideas from the laboratory to people’s lives—not only making scientific breakthroughs, but also working to change individual behaviors, public policies, and health care practices. Each year, more than 400 faculty members at Harvard Chan School teach 1,000-plus full-time students from around the world and train thousands more through online and executive education courses. Founded in 1913 as the Harvard-MIT School of Health Officers, the School is recognized as America’s oldest professional training program in public health.
END
An investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health (NIH). Currently, there is no treatment for GAN and the disease is usually fatal by 30 years of age. Fourteen children with GAN, ages 6 to 14 years, were treated with gene transfer therapy at the NIH Clinical Center and then followed for about six years to assess safety. Results ...
Lithium metal batteries (LMBs) can provide nearly 10 times higher energy density compared to the present Lithium-ion batteries (LIBs) and hence are identified as one of the potential future storage systems. However, LMBs pose certain safety concerns and cannot be used for fast-charging applications. Uncontrolled dendrite formation, leading to excessive heating and battery short circuit is one of the critical challenges of its advancement.
Researchers have previously attempted to address the safety concerns in LMBs but with methods that were laboursome and money/time intensive. T. N. Narayanan’s lab at the Tata Institute ...
IRVINE, CA, March 20, 2024 --The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by funding research breakthroughs, today announced the expansion of its leadership team. Executive Director Jeri Wilson, who has led the organization for 12 years, will step into the newly created role of Vice President of Development, Principal Gifts. Danielle Fragalla, a known nonprofit leader in California, will become Chief Executive Officer.
In the 12 years Ms. Wilson has led the Foundation, it has grown from a grassroots ...
“These results suggest strong potential for clinical use of the assay in ctDNA monitoring of solid tumor cancers.”
BUFFALO, NY- March 20, 2024 – A new research paper was published in Oncotarget's Volume 15 on March 14, 2024, entitled, “Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.”
In this new study, researchers Josette Northcott, Gabor Bartha, Jason Harris, Conan Li, Fabio C.P. Navarro, Rachel Marty Pyke, Manqing Hong, Qi Zhang, Shuyuan Ma, Tina X. Chen, Janet Lai, Nitin Udar, Juan-Sebastian Saldivar, Erin Ayash, ...
The turbulent motion of a tumbling river or the outflow from a jet engine is chaotic: that is, it contains no obvious pattern.
But according to a new study, regular patterns can emerge from the turbulent motion of fluids. What you need is an intriguing property called “odd viscosity” that arises under certain conditions, such as when the particles in the fluid all spin in the same direction. Though it’s a specialized circumstance, there are many contexts in nature where a version of this effect may exist, such as in the ...
COLUMBUS, Ohio — Treating anxiety and depression significantly reduced emergency room visits and rehospitalizations among people with heart disease, according to a study by researchers at The Ohio State University Wexner Medical Center.
“For patients hospitalized for coronary artery disease or heart failure and who had diagnoses of anxiety or depression, treatment with psychotherapy, medication or both was associated with as much as a 75% reduction in hospitalizations or emergency room visits. In some cases, there was a reduction in death,” said lead study author Philip Binkley, MD, executive ...
A study led by University of Oklahoma researchers has been selected for a 2023 best paper award in the Advanced Formation Evaluation technical program theme from the Unconventional Resources Technology Conference.
The study examined how clay and kerogen, two different components within rocks, respond to nuclear magnetic resonance, or NMR, a technique used to assess the amount of fluids within rocks. Many fluids found within rocks contain hydrogen, and knowing whether and how much hydrogen is available in the subsurface is an important facet of oil and gas exploration. Researchers found that higher NMR frequencies improved data acquisition efficiency.
As a result of this study, a ...
“This discovery unveils a potential novel molecular target for therapeutic strategies against hepatic steatosis during the aging process [...]”
BUFFALO, NY- March 20, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 5, entitled, “FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.”
FoxO6, an identified factor, induces hyperlipidemia and hepatic steatosis during aging by activating hepatic ...
Dr. Cochav Elkayam-Levy, of the Hebrew University of Jerusalem awarded the Israel Prize in the field of Solidarity (Arvut Hadadit) for her tireless work to raise awareness and acknowledgement to the crimes committed by Hamas on and following October 7th against Israeli women, children, men and families. Elkayam-Levy established the “Civil Commission on October 7th Crimes by Hamas against Women and Children”, aimed at giving voice to the victims and their families and raising awareness of the concerning developments in war crimes against women, children, men and families on and after October 7th and raising support for this cause.
Dr. Cochav Elkayam-Levy: ...
A new study from the University of Florida's Bureau of Economic and Business Research (BEBR) has found that national elections have a greater impact on consumer sentiment and spending intentions than previously thought, especially during transitions of power between political parties. Led by Hector Sandoval, director of the Economic Analysis Program and research assistant professor at BEBR, the study draws on years of meticulous observation and analysis of monthly sentiments data collected by the UF Survey Research Center.
Despite the wealth of data available ...